Fundz

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

PRIVATEJan 09, 2024

Position

Vice President Of Clinical Research

Company

Zyus

Scott Livingstone
scott.livingstone@zyus.com
SaskatoonManufacturingHealthcare

Description

ZYUS Life Sciences Corporation , a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced that it has strengthened its leadership team with the appointment of Scott Livingstone to the role of Vice President of Clinical Research with its wholly owned subsidiary, ZYUS Life Sciences Inc

Quick answer

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research (January 9, 2024). Zyus is based in Saskatoon, Saskatchewan, Canada.

What did Zyus announce on January 9, 2024?
ZYUS Life Sciences Corporation , a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced that it has strengthened its leadership team with the appointment of Scott Livingstone to the role of Vice President of Clinical Research with its wholly owned subsidiary, ZYUS Life Sciences Inc
What does Zyus do?
Zyus is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management.
Where is Zyus based?
Zyus is based in Saskatoon, Saskatchewan, Canada.
Which similar companies made leadership changes around the same time?
The Cannabist Company Holdings (January 15, 2024), Spineology (January 16, 2024), Apnimed (January 22, 2024) and Allurion Technologies (January 29, 2024) also announced leadership changes within 45 days of Zyus.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Zyus, and when

A new leader at Zyus brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Zyus raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zyus, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zyus. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zyus

Location

407 DOWNEY RD

Saskatoon, Saskatchewan, Canada

About

Zyus is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS’ unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients’ lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zyus changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Keith
Likely contact at this company
••••••••@••••••••

See Keith's verified email →

Scott
Likely contact at this company
••••••••@••••••••

See Scott's verified email →

Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Zyus's next move

Learn about Strategic plan

Zyus changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.